Therapeutic Advances in Chronic Disease (Nov 2023)

The emerging role of digital health in the management of asthma

  • Alan Kaplan,
  • Michael Boivin,
  • Jacques Bouchard,
  • James Kim,
  • Sean Hayes,
  • Christopher Licskai

DOI
https://doi.org/10.1177/20406223231209329
Journal volume & issue
Vol. 14

Abstract

Read online

The most common reasons seen for lack of asthma control include misconceptions about disease control, low controller treatment adherence, poor inhaler technique, and the resulting underuse of controllers and overuse of short-acting beta2 agonists (SABAs). Narrowing these care gaps may be achieved through well-designed patient education that considers the patient’s motivation, beliefs, and capabilities regarding their asthma and its management and empowers the patient to become an active participant in treatment decisions. Digital health technologies (DHTs) and digital therapeutic (DT) devices provide new opportunities to monitor treatment behaviors, improve communication between healthcare providers and patients, and generate data that inform educational interactions. DHT and DT have been proven effective in enhancing patient self-management in other chronic conditions, particularly diabetes. Accelerated integration of DHT and DT into the management of asthma patients is facilitated by the use of digital inhalers that employ sensor technology (“smart” inhalers). These devices efficiently provide real-time feedback on controller adherence, SABA use, and inhaler technique that have the strong potential to optimize asthma control.